BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

544 related articles for article (PubMed ID: 10700238)

  • 1. In vivo antigen challenge in celiac disease identifies a single transglutaminase-modified peptide as the dominant A-gliadin T-cell epitope.
    Anderson RP; Degano P; Godkin AJ; Jewell DP; Hill AV
    Nat Med; 2000 Mar; 6(3):337-42. PubMed ID: 10700238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The intestinal T cell response to alpha-gliadin in adult celiac disease is focused on a single deamidated glutamine targeted by tissue transglutaminase.
    Arentz-Hansen H; Körner R; Molberg O; Quarsten H; Vader W; Kooy YM; Lundin KE; Koning F; Roepstorff P; Sollid LM; McAdam SN
    J Exp Med; 2000 Feb; 191(4):603-12. PubMed ID: 10684852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA binding and T cell recognition of a tissue transglutaminase-modified gliadin epitope.
    Quarsten H; Molberg O; Fugger L; McAdam SN; Sollid LM
    Eur J Immunol; 1999 Aug; 29(8):2506-14. PubMed ID: 10458765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human genome search in celiac disease: mutated gliadin T-cell-like epitope in two human proteins promotes T-cell activation.
    Kumar R; Eastwood AL; Brown ML; Laurie GW
    J Mol Biol; 2002 Jun; 319(3):593-602. PubMed ID: 12054857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T cells from celiac disease lesions recognize gliadin epitopes deamidated in situ by endogenous tissue transglutaminase.
    Molberg O; McAdam S; Lundin KE; Kristiansen C; Arentz-Hansen H; Kett K; Sollid LM
    Eur J Immunol; 2001 May; 31(5):1317-23. PubMed ID: 11465088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T cells in peripheral blood after gluten challenge in coeliac disease.
    Anderson RP; van Heel DA; Tye-Din JA; Barnardo M; Salio M; Jewell DP; Hill AV
    Gut; 2005 Sep; 54(9):1217-23. PubMed ID: 16099789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure of celiac disease-associated HLA-DQ8 and non-associated HLA-DQ9 alleles in complex with two disease-specific epitopes.
    Moustakas AK; van de Wal Y; Routsias J; Kooy YM; van Veelen P; Drijfhout JW; Koning F; Papadopoulos GK
    Int Immunol; 2000 Aug; 12(8):1157-66. PubMed ID: 10917890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resistance to celiac disease in humanized HLA-DR3-DQ2-transgenic mice expressing specific anti-gliadin CD4+ T cells.
    de Kauwe AL; Chen Z; Anderson RP; Keech CL; Price JD; Wijburg O; Jackson DC; Ladhams J; Allison J; McCluskey J
    J Immunol; 2009 Jun; 182(12):7440-50. PubMed ID: 19494267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Celiac lesion T cells recognize epitopes that cluster in regions of gliadins rich in proline residues.
    Arentz-Hansen H; McAdam SN; Molberg Ø; Fleckenstein B; Lundin KE; Jørgensen TJ; Jung G; Roepstorff P; Sollid LM
    Gastroenterology; 2002 Sep; 123(3):803-9. PubMed ID: 12198706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-chain recombinant HLA-DQ2.5/peptide molecules block α2-gliadin-specific pathogenic CD4+ T-cell proliferation and attenuate production of inflammatory cytokines: a potential therapy for celiac disease.
    Huan J; Meza-Romero R; Mooney JL; Vandenbark AA; Offner H; Burrows GG
    Mucosal Immunol; 2011 Jan; 4(1):112-20. PubMed ID: 20736999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease.
    Molberg O; Mcadam SN; Körner R; Quarsten H; Kristiansen C; Madsen L; Fugger L; Scott H; Norén O; Roepstorff P; Lundin KE; Sjöström H; Sollid LM
    Nat Med; 1998 Jun; 4(6):713-7. PubMed ID: 9623982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antagonists and non-toxic variants of the dominant wheat gliadin T cell epitope in coeliac disease.
    Anderson RP; van Heel DA; Tye-Din JA; Jewell DP; Hill AV
    Gut; 2006 Apr; 55(4):485-91. PubMed ID: 16299041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antigen presentation to celiac lesion-derived T cells of a 33-mer gliadin peptide naturally formed by gastrointestinal digestion.
    Qiao SW; Bergseng E; Molberg Ø; Xia J; Fleckenstein B; Khosla C; Sollid LM
    J Immunol; 2004 Aug; 173(3):1757-62. PubMed ID: 15265905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intestinal T cell responses to gluten peptides are largely heterogeneous: implications for a peptide-based therapy in celiac disease.
    Camarca A; Anderson RP; Mamone G; Fierro O; Facchiano A; Costantini S; Zanzi D; Sidney J; Auricchio S; Sette A; Troncone R; Gianfrani C
    J Immunol; 2009 Apr; 182(7):4158-66. PubMed ID: 19299713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of gliadin-specific immune responses in children with HLA-associated genetic risk for celiac disease.
    Lammi A; Arikoski P; Hakulinen A; Schwab U; Uusitupa M; Heinonen S; Savilahti E; Kinnunen T; Ilonen J
    Scand J Gastroenterol; 2016; 51(2):168-77. PubMed ID: 26161465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Refining the rules of gliadin T cell epitope binding to the disease-associated DQ2 molecule in celiac disease: importance of proline spacing and glutamine deamidation.
    Qiao SW; Bergseng E; Molberg O; Jung G; Fleckenstein B; Sollid LM
    J Immunol; 2005 Jul; 175(1):254-61. PubMed ID: 15972656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA-DQ2 and -DQ8 signatures of gluten T cell epitopes in celiac disease.
    Tollefsen S; Arentz-Hansen H; Fleckenstein B; Molberg O; Ráki M; Kwok WW; Jung G; Lundin KE; Sollid LM
    J Clin Invest; 2006 Aug; 116(8):2226-36. PubMed ID: 16878175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T cells recognize a peptide derived from alpha-gliadin presented by the celiac disease-associated HLA-DQ (alpha 1*0501, beta 1*0201) heterodimer.
    Gjertsen HA; Lundin KE; Sollid LM; Eriksen JA; Thorsby E
    Hum Immunol; 1994 Apr; 39(4):243-52. PubMed ID: 7520895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transamidation of wheat flour inhibits the response to gliadin of intestinal T cells in celiac disease.
    Gianfrani C; Siciliano RA; Facchiano AM; Camarca A; Mazzeo MF; Costantini S; Salvati VM; Maurano F; Mazzarella G; Iaquinto G; Bergamo P; Rossi M
    Gastroenterology; 2007 Sep; 133(3):780-9. PubMed ID: 17678925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding of peptides from the N-terminal region of alpha-gliadin to the celiac disease-associated HLA-DQ2 molecule assessed in biochemical and T cell assays.
    Johansen BH; Gjertsen HA; Vartdal F; Buus S; Thorsby E; Lundin KE; Sollid LM
    Clin Immunol Immunopathol; 1996 Jun; 79(3):288-93. PubMed ID: 8635288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.